Deborah Hasin

Deborah Hasin

Deborah Hasin

Epidemiology (in Psychiatry) at the Columbia University Medical Center


722 W. 168th Street, Room 228F
New York New York 10032
Email: CV:


Dr. Hasin is Professor of Epidemiology at Columbia University. She directs the NIDA T32 Substance Abuse Epidemiology Training Program in the Department of Epidemiology in Mailman, and also directs the Substance Dependence Research Group at New York State Psychiatric Institute. Dr. Hasin conducts research on drug and alcohol use and substance use disorders in the general population and in specialized vulnerable groups. She has published over 400 papers. Her studies are funded by the National Institute on Drug Abuse (NIDA), National Institute on Alcohol Abuse and Alcoholism (NIAAA), and other organizations. She currently leads four NIH-funded studies, as well as studies funded by other sources, and sponsors and mentors K and other awards of junior scientists. She has led eight additional NIH-funded research studies in the past, and received NIH Senior Scientist and Mentor awards. Dr. Hasin's current studies include the relationship of state marijuana laws to marijuana and other substances; time trends in drug and alcohol disorders in the U.S.; the validity of DSM-5 definitions of substance and psychiatric disorders in national and clinical populations; and randomized trials of the efficacy of interactive voice response (IVR) and smartphone enhancements of brief interventions to reduce drinking and drug use. Dr. Hasin has participated in World Health Organization studies, served on the National Advisory Council to NIAAA, and been a member of the American Psychiatric Association's DSM-5 Substance Use Disorders Workgroup.



PhD, 1986, Columbia University
MS, 1980, Columbia University
BA, 1972, University of California

Mailman Affiliations

Co-Director, Center for the Study of Social Inequalities and Health

Editorial Boards

Associate Editor, Drug and Alcohol Dependence

Other Affiliations

Member, Research Society on Alcoholism
Member, College on Problems of Drug Dependence
Member, American Psychopathological Association

Honors & Awards

NARSAD Young Investigator Award
NIAAA Senior Scientist and Mentoring Award
Jellinek Memorial Award for Epidemiologic Research on Alcohol

Areas of Expertise

Research Design and Methods, Addiction/Drug Abuse, Addiction/Drug Abuse Treatment, Alcoholism

Select Urban Health Activities

Reducing unsafe drinking in HIV primary care: Binge drinking and drug use in HIV-infected individuals can cause or worsen liver problems, interfere with antiretroviral medication compliance and reduce survival. In large New York City HIV primary care clinics, Dr. Hasin's research group is conducting NIH-funded randomized clinical trials of brief behavioral interventions that employ interactive voice response and smartphone technology to engage patients in brief daily self-monitoring and periodic receipt of personalized feedback.

Select Global Activities

Alcohol in Israel: Genetic and Environmental Effects: Alcohol dependence and heavy drinking are complex traits caused by genetic and environmental factors. In a population-based sample of adult Israeli participants, Dr. Hasin and her colleagues are examining the conjunction of environmental and genetic factors in the risk for alcohol and tobacco problems.

Select Publications

Brown QL, Sarvet AL, Shmulewitz D, Martins SS, Wall MM, Hasin DS. Trends in marijuana use among pregnant and non-pregnant reproductive-aged women, 2002-2014. JAMA. 2017 Jan 10;317(2):207-209.
Cerda M, Wall M, Feng T, Keyes KM, Sarvet A, Schulenberg J, O'Malley PM, Pacula RL, Galea S, Hasin DS. State Recreational Marijuana Laws and Adolescent Marijuana Use. In press, JAMA Pediatrics.
Carliner H, Mauro PM, Brown QL, Shmulewitz D, Rahim R, Sarvet AL, Wall MM, Martins SS, Carliner G, Hasin DS. The Widening Gender Gap in Marijuana Use Prevalence in the U.S. during a Period of Economic Change, 2002-2014. Drug Alch Dependence, 2017 Jan 1;170:51-58.
Hasin DS, Saha TD, Kerridge BT, Goldstein RB, Chou SP, Zhang H, Jung J, Pickering RP, Ruan WJ, Smith SM, Huang B, Grant BF. Marijuana Use Disorders: Increased Prevalence in the United States between 2001-2002 and 2012-2013. JAMA Psychiatry, Published online October 21, 2015. doi:10.1001/jamapsychiatry.2015.1858
Hasin DS, Kerridge BT, Saha TD, Huang B, Pickering R, Smith SM, Jung J, Zhang H, Grant BF. Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions - III. In press, Am J Psychiatry.
Hasin DS, Greenstein E, Aivadyan C, Stohl M, Aharonovich E, Saha T, Goldstein R, Nunes EV, Jung J, Zhang H, Grant BF. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample. Drug Alch Dependence, Drug Alcohol Depend. 2015 Mar 1;148:40-6.
Hasin DS, Wall M, Keyes KM, Cerda M, Schulenberg J, O'Malley PM, Galea S, Pacula RL, Feng T. State Medical Marijuana Laws and Adolescent Marijuana Use in The United States: 1991-2014. Lancet Psychiatry, 2(7): 601-608, 2015 PMID 26303557
Meyers JL, Shmulewitz D, Wall MM, Keyes KM, Aharonovich E, Spivak B, Weizman A, Frisch A, Edenberg HJ, Gelernter J, Grant BF, Hasin D. Childhood adversity moderates the effect of ADH1B on risk for alcohol-related phenotypes in Jewish Israeli drinkers. Addiction Biology. Addict Biol. 2015 Jan;20(1):205-14. PMID: 24164917
Hasin DS, O'Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, Compton WM, Crowley T, Ling W, Petry NM, Schuckit M, Grant BF. DSM- 5 Criteria for Substance Use Disorders: Recommendations and Rationale. American Journal of Psychiatry. 2013 Aug; 170(8):834-51. PMID: 23903334. PMC3767415
Hasin DS, Aharonovich E, O'Leary A, Greenstein E, Pavlicova M, Arunagjadai S, Waxman R, Wainberg M, Helzer J, Johnston B. Reducing Heavy Drinking in HIV Primary Care: A Randomized Trial of Brief Intervention, with and without Technological Enhancement. Addiction. 2013 Jul; 108(7): 1230-1240. PMID: 23432593. PMC3755729

Back to Top